Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

News

Stay up to date on the latest crypto trends with our expert, in-depth coverage.

banner
All
Crypto
Stocks
Commodities & Forex
Macro
Ohio to Accept Bitcoin for State Payments
Ohio to Accept Bitcoin for State Payments

Ohio approves crypto vendor to accept Bitcoin for state fees and services.A Step Toward Mainstream Crypto UsageWhat This Means for Crypto Adoption in the U.S.

Coinomedia·2025/09/25 17:39
Ethereum Bullish Breakout Signals Major Move Ahead
Ethereum Bullish Breakout Signals Major Move Ahead

Ethereum breaks key resistance with a bullish retest, hinting at a potential rally ahead. Here's what it means for ETH investors.Bullish Retest: Market Fear or Smart Opportunity?Ethereum Looks Ready for the Next Leg Up

Coinomedia·2025/09/25 17:39
Altcoin Season Ahead? Bitcoin Dominance Faces Bearish Retest
Altcoin Season Ahead? Bitcoin Dominance Faces Bearish Retest

Bitcoin dominance breaks key support; altcoins could rally if bearish retest is confirmed.What This Means for AltcoinsCaution and Market Sentiment

Coinomedia·2025/09/25 17:39
Altcoin Market Cap Still 23% Below All-Time Highs
Altcoin Market Cap Still 23% Below All-Time Highs

Altcoin market cap remains 23% below 2021 highs, excluding stablecoins. Altseason may not have started yet.Stablecoins Distort the Bigger PictureAltseason Is More Than Just a Chart

Coinomedia·2025/09/25 17:39
Bitcoin Bull Divergences Hint at Bullish Momentum
Bitcoin Bull Divergences Hint at Bullish Momentum

Bitcoin shows multiple bullish divergences, indicating a potential price rebound as bulls regain control.Data Shows Bulls Gaining GroundWhat Could Come Next for Bitcoin?

Coinomedia·2025/09/25 17:39
Flash
12:56
Spot Gold Drops $14 in Short-Term
Spot gold has fallen $14 in the short term, declining over 1.00% during the day, currently reported at $4133.10 per ounce. (Jin Shi)
12:52
Splash Beverage Group Inc. has successfully secured a $1 million strategic investment from C/M Capital Partners.
This funding will be specifically allocated for the development of its Cannepil project.
12:51
Vivos (OTC market code: RDGL) has received Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) and will initiate a human clinical feasibility study of its Radiogel® Precision Radionuclide Therapy™.
This approval marks a key step forward for the clinical application of this innovative therapy, allowing the company to begin initial safety and feasibility assessments in humans. The Radiogel® technology is designed to enable precise radiation treatment within tumors and is expected to provide a new treatment option for cancer patients. The approved clinical study will collect essential data to lay the foundation for larger-scale clinical trials in the future.
News